Laser therapy is reshaping the way clinics treat nail infections. Traditional approaches—such as oral medications or topical antifungals—often deliver inconsistent results, carry health risks, or require long treatment courses.
Today, photobiomodulation devices offer a proven, drug-free alternative. By stimulating natural biological responses using low-intensity light, photobiomodulation allows clinics to address fungal nail infections safely, comfortably, and effectively.
At the forefront of this advancement is Lunula™ Laser by Erchonia®—the world’s first and only fully automated low-level laser device FDA-cleared for the treatment of onychomycosis.
What is Photobiomodulation?
Photobiomodulation (PBM) is the use of specific wavelengths of light to trigger therapeutic changes in cells without generating heat or damaging tissue.
In nail fungus treatment, PBM:
- Stimulates immune cell activity
- Disrupts fungal growth at the cellular level
- Enhances blood flow and tissue regeneration
- Reduces inflammation without invasive intervention
By supporting the body’s natural healing response, photobiomodulation helps eradicate infection while promoting healthy nail regrowth—without the risks associated with systemic antifungal medications.
How Photobiomodulation Targets Nail Fungus
The Lunula™ Laser delivers two distinct wavelengths of light:
- Violet Laser (405nm): Produces Reactive Oxygen Species (ROS), leading to the natural generation of hydrogen peroxide—a potent antiseptic that kills fungal pathogens at the infection site.
- Red Laser (635nm): Stimulates the production of ATP (adenosine triphosphate) and nitric oxide, enhancing immune response, improving circulation, and promoting tissue healing.
This dual action means Lunula™ not only eliminates the fungal infection but also helps restore the nail’s healthy structure and appearance.
Why Clinics Choose Lunula™ Laser for Nail Fungus Treatment
- Fully Automated System: Hands-free, no-contact 12-minute sessions treating all five toes simultaneously.
- Pain-Free and Safe: No discomfort, no heat, no side effects—ideal for all client profiles, including those with medical contraindications to medication.
- High Patient Satisfaction: Natural, progressive results that clients trust.
- Fast ROI: High demand for effective fungal nail solutions ensures strong, reliable return on investment.
- Clinically Proven: Supported by double-blind, placebo-controlled, multi-site clinical studies—the highest standard of medical research.
Lunula™ offers clinics a low-risk, high-reward way to expand their treatment portfolio and meet rising client demand for safer, more natural solutions.
Erchonia®: World Leaders in Cold Laser Therapy Devices
Erchonia® Corporation leads the global market in photobiomodulation (AKA cold laser therapy / low-level laser therapy), holding 22 of the 25 FDA-clearances granted to cold laser therapy devices.
Choosing Erchonia® ensures access to:
- Industry-leading clinical evidence
- Comprehensive device training and marketing support
- Ongoing UK-based technical service and advice
- Proven technologies trusted worldwide by healthcare professionals
Deliver Safer, Proven Results for Nail Fungus
With Lunula™, your clinic can offer clients a superior, non-invasive fungal nail treatment backed by the latest advances in photobiomodulation science.
Contact us today to learn how Lunula™ can grow your clinic’s services and patient satisfaction.
